News & Updates

Treatment with empagliflozin results in a reduction in heart failure (HF) risk and renal outcomes and in better health-related quality of life (HRQoL) among patients with chronic HF with preserved ejection fraction (HFpEF), a study has shown. In addition, the study drug is well tolerated by older patients.

One out of five severe COVID-19 survivors who underwent mechanical ventilation have coronary artery disease (CAD), a quarter have subclinical left ventricular dysfunction defined as reduced echocardiographic global longitudinal strain (GLS), and 42 percent have cardiac magnetic resonance (CMR) abnormalities, reports a study.

Psychological problems, such as anxiety or depression, can negatively affect prognosis and eventual outcomes in patients with inflammatory bowel diseases (IBD), according to a recent study.

Children with ulcerative colitis seem to respond well to vedolizumab in the first-line setting, inducing remission without increasing the risk of adverse events, according to a small study.

The development of acute kidney injury (AKI) seems to worsen the risk of graft loss in kidney transplant recipients (KTRs) with urinary tract infection (UTI), a recent study has found.

Vaginal antisepsis with chlorhexidine proves noninferior to that with iodine in terms of the incidence of gynaecologic surgery-associated urinary tract infection and vaginal irritation, as reported in a study.

Keeping healthy lifestyle habits, such as avoiding smoking, engaging in exercise, and limiting alcohol intake, helps prevent or delay the development of benign prostatic hyperplasia (BPH), a new Japan study has found.